<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00686231</url>
  </required_header>
  <id_info>
    <org_study_id>56438-31921</org_study_id>
    <nct_id>NCT00686231</nct_id>
  </id_info>
  <brief_title>Radial Artery Dilation Study: The Effect of Topical Administration of Nitroglycerin and Lidocaine Versus Lidocaine Alone of the Radial Artery Diameter</brief_title>
  <official_title>The Effect of Topical Administration of Nitroglycerin and Lidocaine Versus Lidocaine Alone of the Radial Artery Diameter</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The radial artery, which is located on the outer side of the forearm, can be used in
      interventional procedures, such as cardiac catheterization, to provide access to the arterial
      blood supply. In order to facilitate successful catheterization of the artery, a dilated
      artery and one free of arterial spasm is desirable. The proposed study will randomize twenty
      three healthy subjects in 2 visits to determine the effect of topical nitroglycerin on radial
      artery vasodilation. Radial artery diameter will be measured with ultrasound at regular
      intervals up to two hours.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      During the first study visit, as a dose-optimizing study, each subject will be randomly
      assigned to one of two Dose-Test arms to receive either 15mg or 30mg of nitroglycerin on one
      wrist and placebo on the other. Radial artery diameter will be measured with ultrasound at
      regular intervals up to two hours. On the second study visit, the same participants will be
      randomly assigned to one of two Combination-Test arms to receive bilateral topical
      application of either 20mg or 40mg of lidocaine; the lidocaine will be applied in combination
      with 30mg of nitroglycerin on one wrist and in combination with placebo on the other wrist.
      Measurements of radial artery diameter will be performed as in the first visit.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2008</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent Change in Diameter of Radial Artery as a Dose Test for Nitroglycerin</measure>
    <time_frame>Baseline, 10 minutes, 30 minutes, 60 minutes, and 120 minutes after topical application at Visit 1</time_frame>
    <description>Radial artery diameter was measured with ultrasonography using a high-frequency (13 MHz) linear array transducer 2 cm proximal to the radial styloid process.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percent Change From Baseline in Radial Artery Diameter to Compare Combination of Nitroglycerin or Placebo and Lidocaine (20mg or 40mg)</measure>
    <time_frame>Baseline, 10 minutes, 30 minutes, 60 minutes, and 120 minutes after topical application at Visit 2</time_frame>
    <description>Radial artery diameter was measured with ultrasonography using a high-frequency (13 MHz) linear array transducer 2 cm proximal to the radial styloid process. To compare combination of (Lidocaine + Nitroglycerin) or (Lidocaine + placebo), at visit 2, participants randomized to Comparison A received 30mg NTG + 20mg Lidocaine on one wrist, and placebo + 20mg Lidocaine on the other wrist; participants randomized to Comparison B received 30mg Nitroglycerin + 40mg Lidocaine on one wrist, and placebo + 40mg Lidocaine on the other wrist.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Dose Test 15mg NTG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nitroglycerin 15mg (NTG) applied topically to one wrist and placebo to the other wrist at Visit 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dose Test 30mg NTG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nitroglycerin 30mg applied topically to one wrist and placebo to the other wrist at Visit 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combination Test 20mg Lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lidocaine 20mg + Nitroglycerin 30mg applied topically to one wrist, Lidocaine 20mg + placebo applied to the other wrist, at Visit 2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combination Test 40mg Lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lidocaine 40mg + Nitroglycerin 30mg applied topically to one wrist, Lidocaine 40mg + placebo applied to the other wrist, at Visit 2</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nitroglycerin 15mg</intervention_name>
    <description>15mg Nitroglycerin applied topically to one wrist</description>
    <arm_group_label>Dose Test 15mg NTG</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nitroglycerin 30mg</intervention_name>
    <description>30mg Nitroglycerin applied topically to one wrist</description>
    <arm_group_label>Combination Test 20mg Lidocaine</arm_group_label>
    <arm_group_label>Combination Test 40mg Lidocaine</arm_group_label>
    <arm_group_label>Dose Test 30mg NTG</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine 20mg</intervention_name>
    <description>20mg Lidocaine applied topically to one wrist in combination with nitroglycerin or placebo</description>
    <arm_group_label>Combination Test 20mg Lidocaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine 40mg</intervention_name>
    <description>40mg Lidocaine applied topically to one wrist in combination with nitroglycerin or placebo</description>
    <arm_group_label>Combination Test 40mg Lidocaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Topical skin moisturizing cream with same appearance as active agent</description>
    <arm_group_label>Combination Test 20mg Lidocaine</arm_group_label>
    <arm_group_label>Combination Test 40mg Lidocaine</arm_group_label>
    <arm_group_label>Dose Test 15mg NTG</arm_group_label>
    <arm_group_label>Dose Test 30mg NTG</arm_group_label>
    <other_name>skin moisturizing cream</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Willing and able to give written informed consent and comply with study requirements

          -  Patient who speak English

        Exclusion Criteria:

          -  Presence or history of liver, cardiovascular, rheumatologic, cancer or renal disease.

          -  Current treatment with any vasodilator therapy

          -  Systolic blood pressure of less than 90 mmHg

          -  History of radial artery catheterization within the previous year

          -  Absence of radial artery blood flow in one or both arms

          -  Pregnancy.

          -  Active infection

          -  Staff members of the Cardiac Catheterization Laboratory.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>UCSF Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>May 19, 2008</study_first_submitted>
  <study_first_submitted_qc>May 28, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 29, 2008</study_first_posted>
  <results_first_submitted>November 12, 2009</results_first_submitted>
  <results_first_submitted_qc>June 23, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 22, 2010</results_first_posted>
  <last_update_submitted>March 4, 2020</last_update_submitted>
  <last_update_submitted_qc>March 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>To determine if topical nitroglycerin acts to vasodilate the radial artery by a direct local action, or by systemic vasodilation</keyword>
  <keyword>To determine if topical nitroglycerin dilates the radial artery in the presence of local anesthetic agents used in cardiac catheterization</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Nitroglycerin</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Dose-test 15mg</title>
          <description>15mg Nitroglycerin on one wrist and Placebo on the other</description>
        </group>
        <group group_id="P2">
          <title>Dose-test 30mg</title>
          <description>30mg Nitroglycerin on one wrist and Placebo on the other</description>
        </group>
        <group group_id="P3">
          <title>Combination Test 20mg</title>
          <description>30mg Nitroglycerin + 20mg Lidocaine on one wrist, and Placebo + 20mg Lidocaine on the other wrist</description>
        </group>
        <group group_id="P4">
          <title>Combination Test 40mg</title>
          <description>30mg Nitroglycerin + 40mg Lidocaine on one wrist, and Placebo + 40mg Lidocaine on the other</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Dose Test - Visit 1</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Combination Test - Visit 2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="10"/>
                <participants group_id="P4" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="10"/>
                <participants group_id="P4" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The PI has left the institution and all efforts to locate per arm data for this module have been exhausted and therefore cannot be reported.</population>
      <group_list>
        <group group_id="B1">
          <title>Overall Study</title>
          <description>Healthy subjects older than 18 years were recruited and randomly assigned to one of two study arms on each of two separate study visits. Visit 1: 15mg Nitroglycerin vs. 30 mg Nitroglycerin on one wrist and placebo on the other wrist. Visit 2: 20mg Lidocaine vs. 40mg Lidocaine in combination with Nitroglycerin on one wrist and with placebo on the other wrist.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="19"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29" spread="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percent Change in Diameter of Radial Artery as a Dose Test for Nitroglycerin</title>
        <description>Radial artery diameter was measured with ultrasonography using a high-frequency (13 MHz) linear array transducer 2 cm proximal to the radial styloid process.</description>
        <time_frame>Baseline, 10 minutes, 30 minutes, 60 minutes, and 120 minutes after topical application at Visit 1</time_frame>
        <population>19 participants were randomized to receive 15mg (n=12) or 30mg (n=7) nitroglycerin on one wrist, and placebo on the other</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Moisturizing skin cream as a matching placebo was topically applied to one wrist, where 15mg or 30mg (by random assignment) Nitroglycerin was applied to the other wrist</description>
          </group>
          <group group_id="O2">
            <title>15mg Nitroglycerin</title>
            <description>15mg of nitroglycerin was administered topically on one wrist (where matching placebo was applied to the other wrist)</description>
          </group>
          <group group_id="O3">
            <title>30mg Nitroglycerin</title>
            <description>30mg of nitroglycerin was administered topically on one wrist (where matching placebo was applied to the other wrist)</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Change in Diameter of Radial Artery as a Dose Test for Nitroglycerin</title>
          <description>Radial artery diameter was measured with ultrasonography using a high-frequency (13 MHz) linear array transducer 2 cm proximal to the radial styloid process.</description>
          <population>19 participants were randomized to receive 15mg (n=12) or 30mg (n=7) nitroglycerin on one wrist, and placebo on the other</population>
          <units>percent diameter change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>radial artery (wrist)</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="7"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>radial artery (wrist)</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>10 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.8" spread="0.5"/>
                    <measurement group_id="O2" value="-0.2" spread="2.8"/>
                    <measurement group_id="O3" value="6.4" spread="4.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5" spread="12.5"/>
                    <measurement group_id="O2" value="0.8" spread="3.5"/>
                    <measurement group_id="O3" value="14.9" spread="18.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" spread="6.5"/>
                    <measurement group_id="O2" value="10.2" spread="5.4"/>
                    <measurement group_id="O3" value="21.5" spread="6.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>120 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.9" spread="6.5"/>
                    <measurement group_id="O2" value="8.8" spread="10.1"/>
                    <measurement group_id="O3" value="28.5" spread="12.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percent Change From Baseline in Radial Artery Diameter to Compare Combination of Nitroglycerin or Placebo and Lidocaine (20mg or 40mg)</title>
        <description>Radial artery diameter was measured with ultrasonography using a high-frequency (13 MHz) linear array transducer 2 cm proximal to the radial styloid process. To compare combination of (Lidocaine + Nitroglycerin) or (Lidocaine + placebo), at visit 2, participants randomized to Comparison A received 30mg NTG + 20mg Lidocaine on one wrist, and placebo + 20mg Lidocaine on the other wrist; participants randomized to Comparison B received 30mg Nitroglycerin + 40mg Lidocaine on one wrist, and placebo + 40mg Lidocaine on the other wrist.</description>
        <time_frame>Baseline, 10 minutes, 30 minutes, 60 minutes, and 120 minutes after topical application at Visit 2</time_frame>
        <population>10 participants (20 wrists) received 30mg NTG + 20mg Lidocaine on one wrist, and placebo + 20mg Lidocaine on the other wrist; 9 participants (18 wrists) received 30mg NTG + 40mg Lidocaine on one wrist, and placebo + 40mg Lidocaine on the other wrist.</population>
        <group_list>
          <group group_id="O1">
            <title>Lidocaine 20mg + Placebo</title>
            <description>20mg combination test: lidocaine + placebo</description>
          </group>
          <group group_id="O2">
            <title>Lidocaine 20mg + Nitroglycerin 30mg</title>
            <description>20mg combination test: lidocaine + nitroglycerin</description>
          </group>
          <group group_id="O3">
            <title>Lidocaine 40mg + Placebo</title>
            <description>40mg combination test: lidocaine + placebo</description>
          </group>
          <group group_id="O4">
            <title>Lidocaine 40mg + Nitroglycerin 30mg</title>
            <description>40mg combination test: lidocaine + nitroglycerin</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Change From Baseline in Radial Artery Diameter to Compare Combination of Nitroglycerin or Placebo and Lidocaine (20mg or 40mg)</title>
          <description>Radial artery diameter was measured with ultrasonography using a high-frequency (13 MHz) linear array transducer 2 cm proximal to the radial styloid process. To compare combination of (Lidocaine + Nitroglycerin) or (Lidocaine + placebo), at visit 2, participants randomized to Comparison A received 30mg NTG + 20mg Lidocaine on one wrist, and placebo + 20mg Lidocaine on the other wrist; participants randomized to Comparison B received 30mg Nitroglycerin + 40mg Lidocaine on one wrist, and placebo + 40mg Lidocaine on the other wrist.</description>
          <population>10 participants (20 wrists) received 30mg NTG + 20mg Lidocaine on one wrist, and placebo + 20mg Lidocaine on the other wrist; 9 participants (18 wrists) received 30mg NTG + 40mg Lidocaine on one wrist, and placebo + 40mg Lidocaine on the other wrist.</population>
          <units>percent diameter change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Radial Artery</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="9"/>
                <count group_id="O4" value="9"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Radial Artery</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="9"/>
                <count group_id="O4" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>10 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" spread="3.6"/>
                    <measurement group_id="O2" value="4.9" spread="7.2"/>
                    <measurement group_id="O3" value="1.6" spread="3.0"/>
                    <measurement group_id="O4" value="3.4" spread="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.3" spread="5.8"/>
                    <measurement group_id="O2" value="11.0" spread="10.6"/>
                    <measurement group_id="O3" value="2.9" spread="1.8"/>
                    <measurement group_id="O4" value="10.6" spread="6.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.4" spread="7.4"/>
                    <measurement group_id="O2" value="18.2" spread="9.4"/>
                    <measurement group_id="O3" value="2.5" spread="3.2"/>
                    <measurement group_id="O4" value="17.2" spread="9.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>120 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.7" spread="6.8"/>
                    <measurement group_id="O2" value="18.5" spread="8.7"/>
                    <measurement group_id="O3" value="4.1" spread="3.9"/>
                    <measurement group_id="O4" value="22.1" spread="12.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Study</title>
          <description>Healthy subjects older than 18 years were recruited and randomly assigned to one of two study arms on each of two separate study visits. Visit 1: 15mg Nitroglycerin vs. 30 mg Nitroglycerin on one wrist and placebo on the other wrist. Visit 2: 20mg Lidocaine vs. 40mg Lidocaine in combination with Nitroglycerin on one wrist and with placebo on the other wrist.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Andrew Boyle</name_or_title>
      <organization>UCSF</organization>
      <phone>415-514-0827</phone>
      <email>aboyle@medicine.ucsf.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

